The embodiments disclose a method including creating a dual product vaporizer for use in vaping two different types of products at the same time, atomizing the two different types of products using two heaters for allowance of different burn temperatures for each of the two different types of products, wherein the two heaters are configured to operate at two different temperatures, wherein the two heaters are configured to operate at the same temperature, wherein the dual product vaporizer is configured to operate with only one product cartridge inserted, using at least one rechargeable battery to power the two heaters and an LED light battery indicator, and using two individual draw holes for drawing atomized product vapors from two individual product cartridges at the same time.

The embodiments disclose a method including creating a dual product vaporizer for use in vaping two different types of products at the same time, atomizing the two different types of products using two heaters for allowance of different burn temperatures for each of the two different types of products, wherein the two heaters are configured to operate at two different temperatures, wherein the two heaters are configured to operate at the same temperature, wherein the dual product vaporizer is configured to operate with only one product cartridge inserted, using at least one rechargeable battery to power the two heaters and an LED light battery indicator, and using two individual draw holes for drawing atomized product vapors from two individual product cartridges at the same time.

A delivery device is disclosed and comprises a housing, a vibration motor for generating haptic feedback to a user, and an elastomeric support member received in the housing. The vibration motor is mounted within the support member. An assembly for insertion into a housing of a delivery device is also disclosed.

An inhaler and a method for adjusting the inhaler for inhaling a liquid pharmaceutical formulation and an inhaler with a nozzle for use with said method. The inhaler includes a mouth piece portion with a lumen and a coupled body portion. The body portion includes a body with a base facing the lumen. The body further has a nozzle with an outlet for discharging said pharmaceutical formulation extending from the base into the lumen, a counter electrode at the base at a counter electrode distance from the nozzle outlet and a discharge electrode at a discharge electrode distance from the nozzle outlet. The inhaler further has a power supply and an air inlet. The method includes a step of adjusting the electrode(s) relative to the nozzle outlet of the inhaler.

Methods and compositions for treating mTBI, PTSD or mTBI with PTSD with psychedelic agents and N-acetylcysteine are provided. Nasal mist transducers for administration of one or more pharmaceutically active ingredients such as these as fine mist particles at preselected dosages and times are also provided.

A system for providing aromatherapy to a user is described herein. The system comprises a mobile computing device including a mobile application to control the system; a diffuser mounted to the mobile computing device, the diffuser including: a body, one or more cavities in the body, one or more heating elements positioned to provide localized heating to the one or more cavities, a processor, and one or more non-transitory computer storage mediums. The system also includes a plurality of carriers including scented material, the carriers sized and configured to reversibly fill a cavity and position scented material proximate a heating element. The non-transitory computer storage mediums are encoded with one or more computer programs that, when executed by the processor in response to instructions from the mobile computing device, instruct the heating elements to apply heat from the heating elements to activate the scented material and deliver a predetermined aromatherapy experience to the user. Corresponding methods also are disclosed.

A system for providing aromatherapy to a user is described herein. The system comprises a mobile computing device including a mobile application to control the system; a diffuser mounted to the mobile computing device, the diffuser including: a body, one or more cavities in the body, one or more heating elements positioned to provide localized heating to the one or more cavities, a processor, and one or more non-transitory computer storage mediums. The system also includes a plurality of carriers including scented material, the carriers sized and configured to reversibly fill a cavity and position scented material proximate a heating element. The non-transitory computer storage mediums are encoded with one or more computer programs that, when executed by the processor in response to instructions from the mobile computing device, instruct the heating elements to apply heat from the heating elements to activate the scented material and deliver a predetermined aromatherapy experience to the user. Corresponding methods also are disclosed.

Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The device makes available for administration the precise quantity of medication constituting a dose at times designated by a health care provider (HCP). Preferably, the device also detects and transmits information to a remote management system accessible to the HCP, including detected attempts to tamper with the device. Advantageously, HCPs may render oversight and control over the device and its use to mitigate risks associated with patients self-administering medication without in-person supervision. This control may include establishing prerequisites the patient must meet prior to a dose being made available, or remote deactivation of the device. This oversight by the HCP may include patient-specific and aggregate data analysis for optimization of treatment or evaluation of the safety and efficacy of a treatment. Furthermore, this oversight may be conducted via a web-based interface.

A method is provided that includes intranasally dispensing nasal wash fluid into a nasal cavity of a subject such that the nasal wash fluid washes biological material into an oropharynx of the subject from (a) the nasal cavity, (b) a nasopharynx of the subject, or (c) the nasal cavity and the nasopharynx. The method further includes, thereafter, collecting a specimen sample that passed out of an anterior opening of an oral cavity of the subject and contains at least a portion of the biological material washed into the oropharynx by the nasal wash fluid. Thereafter, information is derived from extracellular vesicles present in the specimen sample. Other embodiments are also described.

A method is provided that includes intranasally dispensing nasal wash fluid into a nasal cavity of a subject such that the nasal wash fluid washes biological material into an oropharynx of the subject from (a) the nasal cavity, (b) a nasopharynx of the subject, or (c) the nasal cavity and the nasopharynx. The method further includes, thereafter, collecting a specimen sample that passed out of an anterior opening of an oral cavity of the subject and contains at least a portion of the biological material washed into the oropharynx by the nasal wash fluid. Thereafter, information is derived from extracellular vesicles present in the specimen sample. Other embodiments are also described.